Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut ...

Patients with severe aortic stenosis at low surgical risk who underwent supra-annular, self-expanding Evolut transcatheter ...

Patients who underwent transcatheter aortic valve replacement (TAVR) with a valve designed to treat aortic regurgitation had ...

The follow-up brought little surprise, with investigators pleased the risk of death/disabling stroke remained on par with ...

Aortic valve stenosis' is an often-overlooked condition and a growing health concern in ageing societies such as Thailand. With an increasing elderly population and a rise in age-related valve ...

but the treatment options have been more limited for aortic regurgitation, particularly in patients who are too ill to undergo open heart surgery. "These findings represent significant progress in ...

Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...

Patients with symptomatic severe aortic stenosis undergoing CoreValve or Evolut TAVI have better 5-year bioprosthetic valve ...

A WINSFORD couple have undergone the same life-saving heart surgery in the same week. Donald and Joan Curzon, who have been ...

Saad Hasan, MD, cardiothoracic surgeon at The Christ Hospital Health Network, had performed bloodless surgeries before. He was on call the evening of Parker’s aortic dissection and walked to the ...